Northern Trust Corp Increases Stock Holdings in Celsius Holdings Inc. $CELH

Key Points

• Northern Trust Corp increased its stake in Celsius Holdings Inc. by 4.7%, owning 1,411,449 shares valued at $50.3 million as of the last quarter.
• Research analysts have raised their price targets for Celsius shares, with recommendations ranging from "Buy" to "Overweight" and an average consensus price target of $52.28.
• Celsius reported a 83.9% year-over-year revenue growth with $739.3 million in revenue, significantly surpassing analyst estimates of $632.13 million.

Northern Trust Corp increased its position in shares of Celsius Holdings Inc. (NASDAQ:CELH - Free Report) by 4.7% during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,411,449 shares of the company's stock after buying an additional 63,787 shares during the period. Northern Trust Corp owned 0.55% of Celsius worth $50,276,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Alyeska Investment Group L.P. raised its position in shares of Celsius by 60.5% in the fourth quarter. Alyeska Investment Group L.P. now owns 6,877,918 shares of the company's stock worth $181,164,000 after acquiring an additional 2,591,345 shares during the period. Lord Abbett & CO. LLC acquired a new stake in shares of Celsius during the 1st quarter valued at about $36,511,000. Two Sigma Investments LP increased its stake in shares of Celsius by 264.1% in the 4th quarter. Two Sigma Investments LP now owns 894,158 shares of the company's stock valued at $23,552,000 after purchasing an additional 648,582 shares in the last quarter. Nuveen LLC acquired a new position in Celsius in the 1st quarter worth about $17,223,000. Finally, Ameriprise Financial Inc. boosted its position in Celsius by 32.1% during the fourth quarter. Ameriprise Financial Inc. now owns 1,927,192 shares of the company's stock worth $50,761,000 after purchasing an additional 468,094 shares in the last quarter. Institutional investors and hedge funds own 60.95% of the company's stock.

Insider Buying and Selling at Celsius

In related news, CEO John Fieldly sold 143,167 shares of the stock in a transaction that occurred on Thursday, August 7th. The stock was sold at an average price of $51.18, for a total value of $7,327,287.06. Following the completion of the sale, the chief executive officer owned 895,410 shares of the company's stock, valued at approximately $45,827,083.80. This trade represents a 13.78% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, major shareholder Deborah Desantis sold 100,000 shares of Celsius stock in a transaction that occurred on Thursday, July 31st. The stock was sold at an average price of $47.50, for a total value of $4,750,000.00. Following the transaction, the insider owned 17,717,770 shares in the company, valued at approximately $841,594,075. The trade was a 0.56% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 1,116,141 shares of company stock worth $52,541,605 in the last quarter. Insiders own 2.20% of the company's stock.

Analysts Set New Price Targets

A number of analysts have recently commented on CELH shares. Piper Sandler boosted their price objective on Celsius from $44.00 to $45.00 and gave the company an "overweight" rating in a research report on Wednesday, June 4th. JPMorgan Chase & Co. boosted their price target on shares of Celsius from $44.00 to $54.00 and gave the stock an "overweight" rating in a report on Thursday, July 31st. Needham & Company LLC upped their price objective on shares of Celsius from $55.00 to $60.00 and gave the stock a "buy" rating in a research report on Thursday, August 7th. Wells Fargo & Company increased their price objective on shares of Celsius from $44.00 to $45.00 and gave the company an "overweight" rating in a report on Wednesday, June 4th. Finally, Maxim Group lifted their target price on shares of Celsius from $50.00 to $65.00 and gave the company a "buy" rating in a research report on Friday, August 8th. Fifteen equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $53.61.

Celsius Price Performance

NASDAQ CELH traded up $3.19 during mid-day trading on Monday, hitting $62.88. The stock had a trading volume of 10,289,896 shares, compared to its average volume of 8,048,595. The firm's 50 day moving average is $49.73 and its 200 day moving average is $39.95. The company has a debt-to-equity ratio of 0.68, a current ratio of 2.11 and a quick ratio of 1.76. The stock has a market capitalization of $16.22 billion, a price-to-earnings ratio of 169.95, a PEG ratio of 1.43 and a beta of 1.33. Celsius Holdings Inc. has a twelve month low of $21.10 and a twelve month high of $63.50.

Celsius (NASDAQ:CELH - Get Free Report) last released its earnings results on Thursday, August 7th. The company reported $0.47 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.23 by $0.24. The business had revenue of $739.30 million during the quarter, compared to analyst estimates of $632.13 million. Celsius had a net margin of 7.91% and a return on equity of 36.88%. The company's revenue for the quarter was up 83.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.28 earnings per share. Equities research analysts forecast that Celsius Holdings Inc. will post 0.89 earnings per share for the current fiscal year.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.